接种COVID-19疫苗之前和之后的糖尿病发病率 - 来自德国疾病分析数据库的结果
Bernd Kowall1, Karel Kostev2, Rüdiger Landgraf3
1Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany.
Vaccine: X
|July 14, 2023
概括
在德国的一项研究中,COVID-19疫苗接种没有增加糖尿病风险. 疫苗接种后糖尿病发病率较低,这表明需要进一步调查的潜在保护作用.
科学领域:
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
- 内分泌学 在内分泌学.
背景情况:
- 由于COVID-19的流行,需要快速开发和部署疫苗.
- 了解COVID-19疫苗接种对健康的潜在长期影响至关重要.
- 人们担心疫苗接种与糖尿病等慢性疾病之间可能存在关联.
研究的目的:
- 研究COVID-19疫苗接种对糖尿病发病风险的影响.
- 分析COVID-19疫苗接种前后的糖尿病发病率.
主要方法:
- 来自德国疾病分析数据库的6198名患者的回顾性分析.
- 纳入标准:2021年4月至2022年3月期间第一次接种COVID-19疫苗,在接种前或后183天内诊断出糖尿病.
- 疫苗接种日期前后糖尿病发病率的比较.
主要成果:
- 与之前相比,COVID-19疫苗接种后糖尿病发病率较低 (发病率比=0.79,95% CI:0.75-0.83).
- 2021年发生的糖尿病病例总数没有超过2019年观察到的数量.
- 在接种COVID-19疫苗后,没有发现糖尿病风险增加.
结论:
- 该研究没有发现证据支持COVID-19疫苗接种后糖尿病风险增加.
- 结果表明,疫苗接种后糖尿病风险可能会降低,这需要进一步研究.
- 建议继续监测和调查COVID-19疫苗对健康的长期影响.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
600
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
600
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Psychoneuroimmunology: Diabetes and Cancer
49
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
49
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319


